Finance

Lists
Q2 2027 earnings
See results
524516:BOM
Bacil Pharma Ltd
21,41 ₹
-2,46%
(-0,54) 1D
16 қаз., 15:57:51 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524516...
Open
20,86 ₹
High
21,95 ₹
Low
20,86 ₹
Mkt. cap
307,30 млн
Avg. vol.
48,73 мың
Volume
1,20 мың
P/E ratio
38,42
52-wk high
61,80 ₹
52-wk low
10,65 ₹
EPS
0,56 ₹
No. of employees
2
Open
20,86 ₹
High
21,95 ₹
Low
20,86 ₹
Mkt. cap
307,30 млн
Avg. vol.
48,73 мың
Volume
1,20 мың
P/E ratio
38,42
52-wk high
61,80 ₹
52-wk low
10,65 ₹
EPS
0,56 ₹
No. of employees
2
News stories
From web sources and news partners
About Bacil Pharma Ltd
CEO-
Employees2
Founded1987
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 14 қаз.
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
918,00 м. / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
-
-
-
918,00 м.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60,00 мың
109,00 м.
72,00 мың
72,00 мың
Operating expense
253,00 м.
743,00 м.
227,00 м.
593,00 м.
Total operating expenses
253,00 м.
743,00 м.
227,00 м.
593,00 м.
Operating income
-253,00 м.
-743,00 м.
-227,00 м.
325,00 м.
Other non operating income
645,00 м.
-1,22 млн
891,00 м.
-
EBT including unusual items
392,00 м.
390,00 м.
664,00 м.
-299,00 м.
EBT excluding unusual items
392,00 м.
390,00 м.
664,00 м.
-299,00 м.
Income tax expense
-
-7,95 млн
825,00 м.
423,00 м.
Effective tax rate
-
-2 037,95%
124,25%
-141,47%
Other operating expenses
193,00 м.
634,00 м.
155,00 м.
521,00 м.
Net income
392,00 м.
8,34 млн
-161,00 м.
-722,00 м.
Net profit margin
-
-
-
-78,65%
Earnings per share
-
-
-
-
Interest and investment income
-
2,35 млн
-
-
Interest expense
-
-
-
-624,00 м.
Net interest expenses
-
2,35 млн
-
-624,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-251,25 м.
-741,25 м.
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары